JP2021525730A5 - - Google Patents
Info
- Publication number
- JP2021525730A5 JP2021525730A5 JP2020566662A JP2020566662A JP2021525730A5 JP 2021525730 A5 JP2021525730 A5 JP 2021525730A5 JP 2020566662 A JP2020566662 A JP 2020566662A JP 2020566662 A JP2020566662 A JP 2020566662A JP 2021525730 A5 JP2021525730 A5 JP 2021525730A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- heteroaryl
- aryl
- pharmaceutically acceptable
- independently
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862677498P | 2018-05-29 | 2018-05-29 | |
| US62/677,498 | 2018-05-29 | ||
| PCT/IB2019/000691 WO2019229536A2 (en) | 2018-05-29 | 2019-05-29 | Novel benzodiazepine derivatives and uses thereof |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021525730A JP2021525730A (ja) | 2021-09-27 |
| JP2021525730A5 true JP2021525730A5 (https=) | 2022-06-07 |
| JPWO2019229536A5 JPWO2019229536A5 (https=) | 2022-06-07 |
| JP7465819B2 JP7465819B2 (ja) | 2024-04-11 |
Family
ID=68692822
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020566662A Active JP7465819B2 (ja) | 2018-05-29 | 2019-05-29 | 新規ベンゾジアゼピン誘導体及びそれらの使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US11084801B2 (https=) |
| EP (1) | EP3802546A4 (https=) |
| JP (1) | JP7465819B2 (https=) |
| KR (1) | KR102946423B1 (https=) |
| CN (2) | CN113444111A (https=) |
| AU (2) | AU2019276833A1 (https=) |
| BR (1) | BR112020023623A2 (https=) |
| CA (1) | CA3100141A1 (https=) |
| EA (1) | EA202092909A1 (https=) |
| IL (1) | IL278973B2 (https=) |
| MX (1) | MX2020012718A (https=) |
| WO (1) | WO2019229536A2 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019008441A1 (en) | 2017-07-04 | 2019-01-10 | Intocell, Inc. | COMPOUNDS COMPRISING A CLIABABLE BIT AND USES THEREOF |
| MX2020012718A (es) | 2018-05-29 | 2021-02-16 | Intocell Inc | Derivados de benzodiazepinas novedosos y usos de los mismos. |
| KR20210068591A (ko) | 2018-10-31 | 2021-06-09 | 주식회사 인투셀 | 융합된 헤테로시클릭 벤조디아제핀 유도체 및 그의 용도 |
| EP3906064A4 (en) * | 2019-01-03 | 2023-03-08 | Intocell, Inc. | CLEAVABLE LINKER COMPOUNDS AND USES THEREOF |
| WO2020141460A2 (en) | 2019-01-03 | 2020-07-09 | Intocell, Inc. | Compounds comprising cleavable linker and uses thereof |
| KR20220108783A (ko) * | 2019-12-02 | 2022-08-03 | 주식회사 인투셀 | 분자 접합과 관련된 조성물 및 방법 |
| KR20230028793A (ko) * | 2020-06-26 | 2023-03-02 | 주식회사 인투셀 | 항-b7-h3 항체를 포함하는 항체-약물 접합체 |
| CN114805432A (zh) * | 2022-03-03 | 2022-07-29 | 西北工业大学 | 新型可光催化剪切的羧酸保护基及其氨基酸衍生物的制备方法 |
| CN119424671A (zh) | 2023-08-01 | 2025-02-14 | 上海新理念生物医药科技有限公司 | 含糖基吡啶型连接子的抗体药物偶联物 |
| WO2025262641A1 (en) * | 2024-06-19 | 2025-12-26 | Pheon Therapeutics Ltd | Antibody drug conjugates that bind cdcp1 and uses thereof |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5843937A (en) | 1996-05-23 | 1998-12-01 | Panorama Research, Inc. | DNA-binding indole derivatives, their prodrugs and immunoconjugates as anticancer agents |
| GB0819095D0 (en) * | 2008-10-17 | 2008-11-26 | Spirogen Ltd | Pyrrolobenzodiazepines |
| CN102365021B (zh) | 2009-02-05 | 2015-07-15 | 伊缪诺金公司 | 新型苯并二氮杂*衍生物 |
| CA2850103C (en) * | 2011-10-14 | 2019-09-10 | Spirogen Sarl | Pyrrolobenzodiazepines |
| WO2013055993A1 (en) * | 2011-10-14 | 2013-04-18 | Seattle Genetics, Inc. | Pyrrolobenzodiazepines and targeted conjugates |
| HK1211208A1 (zh) | 2012-08-22 | 2016-05-20 | Immunogen, Inc. | 細胞毒性苯並二氮呯衍生物 |
| US10131682B2 (en) | 2012-11-24 | 2018-11-20 | Hangzhou Dac Biotech Co., Ltd. | Hydrophilic linkers and their uses for conjugation of drugs to a cell binding molecules |
| RU2729194C2 (ru) * | 2013-12-27 | 2020-08-05 | Займворкс Инк. | Сульфонамидсодержащие связывающие системы для лекарственных конъюгатов |
| EP3160513B1 (en) | 2014-06-30 | 2020-02-12 | Glykos Finland Oy | Saccharide derivative of a toxic payload and antibody conjugates thereof |
| TW201632531A (zh) * | 2015-01-14 | 2016-09-16 | 必治妥美雅史谷比公司 | 苯二氮呯二聚物，其結合物及製造與使用方法 |
| JP6676058B2 (ja) * | 2015-01-14 | 2020-04-08 | ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ | ヘテロアリーレン架橋したベンゾジアゼピン二量体、そのコンジュゲート、ならびに製造および使用方法 |
| MX382582B (es) | 2015-03-18 | 2025-03-13 | Seagen Inc | Anticuerpos contra cúmulo de diferenciación 48 (cd48) y sus conjugados. |
| US9504694B2 (en) * | 2015-03-19 | 2016-11-29 | Cellerant Therapeutics, Inc. | Isoquinolidinobenzodiazepines |
| JP2019516705A (ja) * | 2016-05-20 | 2019-06-20 | アッヴィ・ステムセントルクス・エル・エル・シー | 神経内分泌移行のリスクのある腫瘍を治療するための抗ｄｌｌ３薬物コンジュゲート |
| WO2018053552A2 (en) * | 2016-09-19 | 2018-03-22 | Cellerant Therapeutics, Inc. | Isoquinolidinobenzodiazepines |
| GB201617466D0 (en) | 2016-10-14 | 2016-11-30 | Medimmune Ltd | Pyrrolobenzodiazepine conjugates |
| AU2018237683A1 (en) * | 2017-03-24 | 2019-10-31 | Seagen Inc. | Process for the preparation of glucuronide drug-linkers and intermediates thereof |
| WO2018195243A1 (en) | 2017-04-20 | 2018-10-25 | Immunogen, Inc. | Cytotoxic benzodiazepine derivatives and conjugates thereof |
| WO2019008441A1 (en) * | 2017-07-04 | 2019-01-10 | Intocell, Inc. | COMPOUNDS COMPRISING A CLIABABLE BIT AND USES THEREOF |
| GB201714115D0 (en) * | 2017-09-04 | 2017-10-18 | Femtogenix Ltd | Cytotoxic agents |
| MX2020012718A (es) | 2018-05-29 | 2021-02-16 | Intocell Inc | Derivados de benzodiazepinas novedosos y usos de los mismos. |
| KR20210068591A (ko) | 2018-10-31 | 2021-06-09 | 주식회사 인투셀 | 융합된 헤테로시클릭 벤조디아제핀 유도체 및 그의 용도 |
| KR102503143B1 (ko) | 2019-03-06 | 2023-02-24 | 주식회사 레고켐 바이오사이언스 | 인간 dlk1에 대한 항체를 포함하는 항체 약물 접합체 및 이의 용도 |
| KR20230028793A (ko) | 2020-06-26 | 2023-03-02 | 주식회사 인투셀 | 항-b7-h3 항체를 포함하는 항체-약물 접합체 |
-
2019
- 2019-05-29 MX MX2020012718A patent/MX2020012718A/es unknown
- 2019-05-29 IL IL278973A patent/IL278973B2/en unknown
- 2019-05-29 EA EA202092909A patent/EA202092909A1/ru unknown
- 2019-05-29 AU AU2019276833A patent/AU2019276833A1/en not_active Abandoned
- 2019-05-29 WO PCT/IB2019/000691 patent/WO2019229536A2/en not_active Ceased
- 2019-05-29 CA CA3100141A patent/CA3100141A1/en active Pending
- 2019-05-29 CN CN202110592302.2A patent/CN113444111A/zh active Pending
- 2019-05-29 JP JP2020566662A patent/JP7465819B2/ja active Active
- 2019-05-29 BR BR112020023623-3A patent/BR112020023623A2/pt unknown
- 2019-05-29 EP EP19811692.3A patent/EP3802546A4/en active Pending
- 2019-05-29 KR KR1020207037031A patent/KR102946423B1/ko active Active
- 2019-05-29 US US16/425,237 patent/US11084801B2/en active Active
- 2019-05-29 CN CN201980035084.3A patent/CN112166115A/zh active Pending
-
2021
- 2021-06-30 US US17/363,814 patent/US11807628B2/en active Active
-
2023
- 2023-06-05 AU AU2023203485A patent/AU2023203485B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021525730A5 (https=) | ||
| JP7229202B2 (ja) | 標的化薬物結合体と使用するためのメチレンカルバメートリンカー | |
| CN101909441B (zh) | 微管蛋白抑制剂及其制备方法 | |
| FI105155B (fi) | Menetelmä terapeuttisesti käyttökelpoisten sappihappojohdannaisten valmistamiseksi | |
| JP2025510629A (ja) | カンプトテシンコンジュゲート | |
| JP2022082777A (ja) | Ｐｅｇ化薬物リンカー及びその中間体を調製するためのプロセス | |
| JP2022529854A (ja) | カンプトテシン誘導体 | |
| JP2023105175A (ja) | グルクロニド薬物－リンカーの調製のためのプロセスおよびその中間体 | |
| MXPA05010471A (es) | Profarmacos inhibidores de quinasa pi-3. | |
| JP6929292B2 (ja) | 新規なクリプトフィシン化合物およびコンジュゲート、これらの製造およびこれらの治療用途 | |
| IL315310A (en) | Irak degraders and uses thereof | |
| JPWO2020206424A5 (https=) | ||
| US20090246211A1 (en) | Molecular constructs suitable for targeted conjugates | |
| KR20220052918A (ko) | 치료제로서의 사이토톡신의 펩티드 접합체 | |
| JP2006523237A5 (https=) | ||
| JP2012516896A5 (https=) | ||
| KR20160045146A (ko) | 마크롤라이드 디아스테레오머를 포함하는 약제학적 조성물, 이의 합성 방법 및 치료학적 용도 | |
| CN105899515A (zh) | uncialamycin的衍生物、合成方法及其作为抗肿瘤剂的用途 | |
| JPWO2019140301A5 (https=) | ||
| JPWO2020236817A5 (https=) | ||
| JP2018512424A (ja) | エステル化のための試薬及び方法 | |
| JPWO2019229536A5 (https=) | ||
| JPWO2020089687A5 (https=) | ||
| Makarov et al. | Modification of 3, 5-bis (arylidene)-4-piperidone pharmacophore by phosphonate group using 1, 2, 3-triazole cycle as a linker for the synthesis of new cytostatics | |
| JP2021531269A (ja) | チオシクロへプチン誘導体およびその使用 |